FDAAA Basic Results Reporting: First Experience and Challenges

Title VIII of the Food and Drug Administration Amendments Act (FDAAA) has required basic results reporting from interventional clinical studies in a tabular format since September 27, 2008, on the US government website ClinicalTrials.gov. The State of Maine also required study results posting (inclu...

Full description

Saved in:
Bibliographic Details
Published in:Drug information journal 2011-05, Vol.45 (3), p.245-252
Main Authors: Forst, Hans-Theo, Paarlberg, Robert, Roberts, Elizabeth
Format: Article
Language:English
Subjects:
Adverse events
Clinical medicine
Clinical trials
Confidence intervals
Drug Safety and Pharmacovigilance
Pharmaceutical industry
Pharmacotherapy
Pharmacy
Regulatory Affairs
Reporting requirements
State laws
Studies
Web sites
Websites
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Title VIII of the Food and Drug Administration Amendments Act (FDAAA) has required basic results reporting from interventional clinical studies in a tabular format since September 27, 2008, on the US government website ClinicalTrials.gov. The State of Maine also required study results posting (including adverse event data) as of December 8, 2008. In addition to the already existing Protocol Registration System (PRS), the National Library of Medicine has developed a Results Registration System (RRS) with an entry application on the website that prepopulates table shells for results entry on the basis of the information in the PRS. Participant Flow, Baseline Characteristics, Outcome Measures, and Reported Adverse Events are the main modules of the RRS. At UCB we have entered results from more than 30 studies in RRS. This article reports our first experiences with basic results reporting from the perspective of a midsized pharmaceutical company, describes the challenges faced in establishing processes to enable results entry, and provides recommendations to improve the current RRS.
ISSN:2168-4790
0092-8615
2168-4804
2164-9200
DOI:10.1177/009286151104500305